NOS2 and asthma: Attenuation of the insulin resistance of obese mice by the anti-hyperglycemic drug metformin attenuates the eosinophilic airway inflammation and iNOS-derived NO concentrations to the levels of lean asthmatic group, suggesting that systemic insulin resistance play a role in asthma exacerbation in obesity conditions9.